SMS Pharmaceuticals Ltd Schedules Board Meeting to Approve Q1 Financial ResultsSMS Pharmaceuticals Limited has scheduled a meeting of its Board of Directors to consider and approve the Unaudited (Standalone and Consolidated) Financial Results for the first quarter ending June 30, 2026.The Board meeting is set to take place on Saturday, August 1, 2026, at the company's registered office. The primary objective of the meeting is the review and approval of the financial results pertaining to the first quarter concluded on June 30, 2026.In adherence to established protocols regarding the prevention of insider trading, SMS Pharmaceuticals Limited has announced details concerning the trading window for its equity shares. The company...